Search research articles
Contact Us
Filters
Showing results (31-40 of 63) with videos related to
Page
of 7
Sort By:
BMJ (Clinical Research Ed.)
|
March 18, 2021
Clustering and longitudinal change in SARS-CoV-2 seroprevalence in school children in the canton of Zurich, Switzerland: prospective cohort study of 55 schools
Agne Ulyte, Thomas Radtke, Irene A Abela, et al.
HIV Medicine
|
February 23, 2022
Women with HIV transitioning through menopause: Insights from the Swiss HIV Cohort Study (SHCS)
Anna Hachfeld, Andrew Atkinson, Petra Stute, et al.
The Journal of Infectious Diseases
|
June 1, 2023
Seroprofiling of Antibodies Against Endemic Human Coronaviruses and Severe Acute Respiratory Syndrome Coronavirus 2 in a Human Immunodeficiency Virus Cohort in Lesotho: Correlates of Antibody Response and Seropositivity
Jennifer A Brown, Anthony Hauser, Irene A Abela, et al.
The Journal of Experimental Medicine
|
March 2, 2011
MPER-specific antibodies induce gp120 shedding and irreversibly neutralize HIV-1
Claudia R Ruprecht, Anders Krarup, Lucy Reynell, et al.
HIV Medicine
|
November 11, 2025
Factors associated with uptake of gynaecological care and cervical cancer screening among women in the Swiss HIV Cohort Study
Mailin Waldecker, Katayoun Taghavi, Chloe Pasin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 3, 2023
Brief Report: Does Menopause Transition Influence Viral Suppression and Adherence in Women Living With HIV?
Anna Hachfeld, Andrew Atkinson, Petra Stute, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 8, 2019
Emergence of Drug Resistance in the Swiss HIV Cohort Study Under Potent Antiretroviral Therapy Is Observed in Socially Disadvantaged Patients
Irene A Abela, Alexandra U Scherrer, Jürg Böni, et al.
Cell Reports. Medicine
|
August 31, 2024
Decoupling HIV-1 antiretroviral drug inhibition from plasma antibody activity to evaluate broadly neutralizing antibody therapeutics and vaccines
Magdalena Schwarzmüller, Cristina Lozano, Merle Schanz, et al.
RMD Open
|
October 26, 2022
Postvaccination anti-S IgG levels predict anti-SARS-CoV-2 neutralising activity over 24 weeks in patients with RA
Kristin Schmiedeberg, Irene A Abela, Natalia Barbara Pikor, et al.
Open Forum Infectious Diseases
|
September 19, 2024
Gender Disparities in Statin Prescriptions in People With HIV With Low/Moderate to High Cardiovascular Risk
Irene A Abela, Frédérique Chammartin, Alain Amstutz, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 63) with videos related to
Sort By:
Page
of 7
BMJ (Clinical Research Ed.)
|
March 18, 2021
Clustering and longitudinal change in SARS-CoV-2 seroprevalence in school children in the canton of Zurich, Switzerland: prospective cohort study of 55 schools
Agne Ulyte, Thomas Radtke, Irene A Abela, et al.
HIV Medicine
|
February 23, 2022
Women with HIV transitioning through menopause: Insights from the Swiss HIV Cohort Study (SHCS)
Anna Hachfeld, Andrew Atkinson, Petra Stute, et al.
The Journal of Infectious Diseases
|
June 1, 2023
Seroprofiling of Antibodies Against Endemic Human Coronaviruses and Severe Acute Respiratory Syndrome Coronavirus 2 in a Human Immunodeficiency Virus Cohort in Lesotho: Correlates of Antibody Response and Seropositivity
Jennifer A Brown, Anthony Hauser, Irene A Abela, et al.
The Journal of Experimental Medicine
|
March 2, 2011
MPER-specific antibodies induce gp120 shedding and irreversibly neutralize HIV-1
Claudia R Ruprecht, Anders Krarup, Lucy Reynell, et al.
HIV Medicine
|
November 11, 2025
Factors associated with uptake of gynaecological care and cervical cancer screening among women in the Swiss HIV Cohort Study
Mailin Waldecker, Katayoun Taghavi, Chloe Pasin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 3, 2023
Brief Report: Does Menopause Transition Influence Viral Suppression and Adherence in Women Living With HIV?
Anna Hachfeld, Andrew Atkinson, Petra Stute, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 8, 2019
Emergence of Drug Resistance in the Swiss HIV Cohort Study Under Potent Antiretroviral Therapy Is Observed in Socially Disadvantaged Patients
Irene A Abela, Alexandra U Scherrer, Jürg Böni, et al.
Cell Reports. Medicine
|
August 31, 2024
Decoupling HIV-1 antiretroviral drug inhibition from plasma antibody activity to evaluate broadly neutralizing antibody therapeutics and vaccines
Magdalena Schwarzmüller, Cristina Lozano, Merle Schanz, et al.
RMD Open
|
October 26, 2022
Postvaccination anti-S IgG levels predict anti-SARS-CoV-2 neutralising activity over 24 weeks in patients with RA
Kristin Schmiedeberg, Irene A Abela, Natalia Barbara Pikor, et al.
Open Forum Infectious Diseases
|
September 19, 2024
Gender Disparities in Statin Prescriptions in People With HIV With Low/Moderate to High Cardiovascular Risk
Irene A Abela, Frédérique Chammartin, Alain Amstutz, et al.
Page
of 7